LMRI · Lumexa Imaging Holdings Inc. Common Stock
View on chartInsiders & Stakes
| Julie Szeker Chief Legal Officer & Corp Sec | ▲ Buy | Grant | 147,263 Shares held | 12/12/2025 | View profile |
| Caitlin Zulla Chief Executive Officer | ▲ Buy | Grant | 129,728 Shares held | 12/12/2025 | View profile |
| Brett Brodnax | ▲ Buy | Grant | 81,385 Shares held | 6/10/2026 | View profile |
| James Anthony Martin Chief Financial Officer | ▲ Buy | Grant | 54,054 Shares held | 12/12/2025 | View profile |
| Molly Joseph Director | ▲ Buy | Grant | 46,385 Shares held | 6/10/2026 | View profile |
| Glenn A. Eisenberg Director | ▲ Buy | Grant | 19,358 Shares held | 6/10/2026 | View profile |
| Robert Louis Mittl Jr. | ▲ Buy | Grant | 19,358 Shares held | 6/10/2026 | View profile |
| Matthew Lungren | ▲ Buy | Grant | 19,358 Shares held | 6/10/2026 | View profile |
| Bridget E. Karlin Director | ▲ Buy | Grant | 19,358 Shares held | 6/10/2026 | View profile |
| Henry Lee Cooper | ▲ Buy | Grant | 19,358 Shares held | 6/10/2026 | View profile |
| James Edward Walker Jr. Principal Accounting Officer | ▲ Buy | Grant | 17,346 Shares held | 2/25/2026 | View profile |
| Russell Stewart Chief Medical Officer | ▲ Buy | Grant | 8,464 Shares held | 12/12/2025 | View profile |
Transaction History
| Robert Louis Mittl Jr. | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Matthew Lungren | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Bridget E. Karlin | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Molly Joseph | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Glenn A. Eisenberg | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Henry Lee Cooper | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Brett Brodnax | ▲ Buy | Grant | 19,358 | $0 | 6/10/2026 |
| Brett Brodnax | ▲ Buy | Open Market | 35,000 | $254K | 5/19/2026 |
| Henry Lee Cooper | ▲ Buy | Open Market | 30,000 | $223K | 5/14/2026 |
| James Edward Walker Jr. | ▲ Buy | Grant | 12,414 | $0 | 2/25/2026 |
| Russell Stewart | ▲ Buy | Grant | 4,232 | $0 | 12/12/2025 |
| Russell Stewart | ▲ Buy | Grant | 4,232 | $0 | 12/12/2025 |
| James Anthony Martin | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 |
| James Anthony Martin | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 |
| James Edward Walker Jr. | ▲ Buy | Grant | 4,932 | $0 | 12/12/2025 |
| Caitlin Zulla | ▲ Buy | Grant | 64,864 | $0 | 12/12/2025 |
| Caitlin Zulla | ▲ Buy | Grant | 64,864 | $0 | 12/12/2025 |
| Brett Brodnax | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 |
| Molly Joseph | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 |
| Julie Szeker | ▲ Buy | Option Exercise | 66,182 | — | 12/12/2025 |
| Julie Szeker | ▲ Buy | Grant | 81,081 | $0 | 12/12/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Lumexa Imaging (LMRI) Valuation Analysis Published
A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.
Lumexa Imaging (LMRI) Valuation Analysis Published. A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.